ロード中...
Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure
BACKGROUND: There is currently insufficient information available on effective therapies that can be administered to patients with non‐small cell cancer (NSCLC) who develop resistance to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs). However, sequential treatment via progra...
保存先:
| 出版年: | Thorac Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons Australia, Ltd
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952801/ https://ncbi.nlm.nih.gov/pubmed/33522139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13864 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|